Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae
- PMID: 19258277
- PMCID: PMC2681557
- DOI: 10.1128/AAC.00020-09
Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae
Abstract
The opportunistic mold Fusarium solani is intrinsically resistant to cell wall synthesis-inhibiting echinocandins (ECs), including caspofungin and micafungin. Mutations that confer acquired EC resistance in Saccharomyces cerevisiae and other normally susceptible yeast species have been mapped to the Fks1 gene; among these is the mutation of residue 639 from Phe to Tyr (F639Y) within a region designated hot spot 1. Fks1 sequence analysis identified the equivalent of Y639 in F. solani as well as in Scedosporium prolificans, another intrinsically EC-resistant mold. To test its role in intrinsic EC resistance, we constructed Fks1 hybrids in S. cerevisiae that incorporate F. solani hot spot 1 and flanking residues. Hybrid construction was accomplished by a PCR-based method that was validated by studies with Fks1 sequences from EC-susceptible Aspergillus fumigatus and paired EC-susceptible and -resistant Candida glabrata isolates. In support of our hypothesis, hybrid Fks1 incorporating F. solani hot spot 1 conferred significantly reduced EC susceptibility, 4- to 8-fold less than that of wild-type S. cerevisiae and 8- to 32-fold less than that of the same hybrid with an F639 mutation. We propose that Fks1 sequences represent determinants of intrinsic EC resistance in Fusarium and Scedosporium species and, potentially, other fungi.
Figures


Similar articles
-
New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium species.Antimicrob Agents Chemother. 2011 Aug;55(8):3774-81. doi: 10.1128/AAC.01811-10. Epub 2011 May 16. Antimicrob Agents Chemother. 2011. PMID: 21576441 Free PMC article.
-
Molecular Confirmation of the Relationship between Candida guilliermondii Fks1p Naturally Occurring Amino Acid Substitutions and Its Intrinsic Reduced Echinocandin Susceptibility.Antimicrob Agents Chemother. 2017 Apr 24;61(5):e02644-16. doi: 10.1128/AAC.02644-16. Print 2017 May. Antimicrob Agents Chemother. 2017. PMID: 28242659 Free PMC article.
-
Topological and mutational analysis of Saccharomyces cerevisiae Fks1.Eukaryot Cell. 2012 Jul;11(7):952-60. doi: 10.1128/EC.00082-12. Epub 2012 May 11. Eukaryot Cell. 2012. PMID: 22581527 Free PMC article.
-
Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.Dan Med J. 2016 Oct;63(10):B5288. Dan Med J. 2016. PMID: 27697142 Review.
-
Resistance to echinocandin-class antifungal drugs.Drug Resist Updat. 2007 Jun;10(3):121-30. doi: 10.1016/j.drup.2007.04.002. Epub 2007 Jun 13. Drug Resist Updat. 2007. PMID: 17569573 Free PMC article. Review.
Cited by
-
Fungicide resistance in Fusarium species: exploring environmental impacts and sustainable management strategies.Arch Microbiol. 2025 Jan 10;207(2):31. doi: 10.1007/s00203-024-04219-6. Arch Microbiol. 2025. PMID: 39792175 Review.
-
Echinocandin Resistance in Candida.Clin Infect Dis. 2015 Dec 1;61 Suppl 6(Suppl 6):S612-7. doi: 10.1093/cid/civ791. Clin Infect Dis. 2015. PMID: 26567278 Free PMC article.
-
Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi.Mediators Inflamm. 2017;2017:9870679. doi: 10.1155/2017/9870679. Epub 2017 Jun 13. Mediators Inflamm. 2017. PMID: 28694566 Free PMC article. Review.
-
Favourable outcome of Fusarium prosthetic valve endocarditis in a patient with an Ebstein anomaly.S Afr J Infect Dis. 2025 Feb 11;40(1):699. doi: 10.4102/sajid.v40i1.699. eCollection 2025. S Afr J Infect Dis. 2025. PMID: 40060086 Free PMC article.
-
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease.Clin Microbiol Rev. 2024 Jun 13;37(2):e0007423. doi: 10.1128/cmr.00074-23. Epub 2024 Apr 11. Clin Microbiol Rev. 2024. PMID: 38602408 Free PMC article. Review.
References
-
- Cornely, O. A. 2008. Aspergillus to zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections. Infection 36:296-313. - PubMed
-
- Cuenca-Estrella, M., A. Gomez-Lopez, E. Mellado, M. J. Buitrago, A. Monzon, and J. L. Rodriguez-Tudela. 2006. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob. Agents Chemother. 50:917-921. - PMC - PubMed
-
- Denning, D. W. 2003. Echinocandin antifungal drugs. Lancet 362:1142-1151. - PubMed
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Molecular Biology Databases